EUVIMEDEUVIMED entdecken
Crossref

Evaluation of anti-inflammatory and anti-arthritic activities of Benzimidazole derivative 2-((1H-benzo[d]imiadazol-2-yl) thio)-1-3, 5-diphenyl-1h-pyrazol-1-yl) ethanone

Aisha Mobashar, Komal Najam, Zeeshan Akbar, Kashif Barkat, Khalid Hussain, Humaira Nadeem, Hafiz Aamir Ali Kharl, Muftia Arubah Basri

Atlantic Journal of Life Sciences · 2025

DOI: 10.71005/z815ma53 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Atlantic Journal of Life Sciences, 2025. Verfasst von Aisha Mobashar und 7 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates the anti-inflammatory and immunomodulatory effects of a Benzimidazole derivative 2-((1H-benzo[d]imiadazol-2-yl) thio)-1-3, 5-diphenyl-1h-pyrazol-1-yl)ethanone (BZ), in both chronic and acute inflammation models. For induction of arthritis, Freund’s Complete Adjuvant was used. After inducing arthritis in rats, three different doses of benzimidazole derivative (25,50 and 100 mg/kg) were given. The treatment started on the 7th day and continued for 3 weeks. Piroxicam was used as the standard drug. On the last day of treatment, the rats were sacrificed. Paw edema and arthritis were determined using digital water plethysmometry and arthritic score index. Various hematological parameters, including red blood cells (RBC), white blood cells (WBC) and hemoglobin (Hb), along with biochemical markers such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), urea and creatinine were also evaluated. The mRNA levels of IL-6 and TNF-α were determined using a quantitative polymerase chain reaction (qPCR). Prostaglandin E2 (PGE2) levels were measured via ELISA. Carrageenan induced paw edema was employed for determining anti-inflammatory activity. Treatment with different doses of Benzimidazole derivative decreased paw edema and decreased arthritic progression. All histopathological parameters were concluded to be decreased after the given treatment. The analysis of qPCR showed decreased levels of Tumour necrosis factor (TNF-α) and Interleukin-6 (IL-6). Enzyme-linked immunosorbent assay (ELISA) demonstrated a decreased level of PGE2 in all groups that were treated with the benzimidazole derivative. Results obtained from all groups treated with the benzimidazole derivative were significantly comparable to those of piroxicam. Treatment groups restored RBC and Hb levels. The Benzimidazole derivative exhibited significant anti-inflammatory and immunomodulatory effects by reducing paw edema, arthritic progression, and inflammatory markers (TNF-α, IL-6, and PGE2), demonstrating potential as a therapeutic agent for inflammatory conditions.

Zitieren

APA

Mobashar, A., Najam, K., Akbar, Z., Barkat, K., Hussain, K., Nadeem, H., Kharl, H. A. A., & Basri, M. A. (2025). Evaluation of anti-inflammatory and anti-arthritic activities of Benzimidazole derivative 2-((1H-benzo[d]imiadazol-2-yl) thio)-1-3, 5-diphenyl-1h-pyrazol-1-yl) ethanone. Atlantic Journal of Life Sciences. https://doi.org/10.71005/z815ma53

Vancouver

Mobashar A, Najam K, Akbar Z, Barkat K, Hussain K, Nadeem H, et al. Evaluation of anti-inflammatory and anti-arthritic activities of Benzimidazole derivative 2-((1H-benzo[d]imiadazol-2-yl) thio)-1-3, 5-diphenyl-1h-pyrazol-1-yl) ethanone. Atlantic Journal of Life Sciences. 2025. doi:10.71005/z815ma53

BibTeX
@article{Mobashar2025,
  author = {Mobashar, Aisha and Najam, Komal and Akbar, Zeeshan and Barkat, Kashif and Hussain, Khalid and Nadeem, Humaira and Kharl, Hafiz Aamir Ali and Basri, Muftia Arubah},
  title = {Evaluation of anti-inflammatory and anti-arthritic activities of Benzimidazole derivative 2-((1H-benzo[d]imiadazol-2-yl) thio)-1-3, 5-diphenyl-1h-pyrazol-1-yl) ethanone},
  journal = {Atlantic Journal of Life Sciences},
  year = {2025},
  doi = {10.71005/z815ma53}
}
Kostenlos starten →